SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Adriana Migliorini, Hans-Joachim Anders, A novel pathogenetic concept—antiviral immunity in lupus nephritis, Nature Reviews Nephrology, 2012, 8, 3, 183

    CrossRef

  2. 2
    Bevra H. Hahn, Maureen A. McMahon, Alan Wilkinson, W. Dean Wallace, David I. Daikh, John D. FitzGerald, George A. Karpouzas, Joan T. Merrill, Daniel J. Wallace, Jinoos Yazdany, Rosalind Ramsey-Goldman, Karandeep Singh, Mazdak Khalighi, Soo-In Choi, Maneesh Gogia, Suzanne Kafaja, Mohammad Kamgar, Christine Lau, William J. Martin, Sefali Parikh, Justin Peng, Anjay Rastogi, Weiling Chen, Jennifer M. Grossman, American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis, Arthritis Care & Research, 2012, 64, 6
  3. 3
    G. J. Pons-Estel, G. S. Alarcon, L. Hachuel, G. Boggio, D. Wojdyla, V. Pascual-Ramos, E. R. Soriano, V. Saurit, F. S. Cavalcanti, R. A. Guzman, M. Guibert-Toledano, M. J. Sauza del Pozo, M.-C. Amigo, M. Alva, M. H. Esteva-Spinetti, B. A. Pons-Estel, Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort, Rheumatology, 2012,

    CrossRef

  4. 4
    Chapter 12: Lupus nephritis, Kidney International Supplements, 2012, 2, 2, 221

    CrossRef

  5. 5
    G. Ruiz-Irastorza, G. Espinosa, M.A. Frutos, J. Jiménez Alonso, M. Praga, L. Pallarés, F. Rivera, Á. Robles Marhuenda, A. Segarra, C. Quereda, Diagnóstico y tratamiento de la nefritis lúpica, Revista Clínica Española, 2012, 212, 3, 147.e1

    CrossRef

  6. 6
    Anne V. Miller, Sriya K.M. Ranatunga, Immunotherapies in Rheumatologic Disorders, Medical Clinics of North America, 2012,

    CrossRef

  7. 7
    M. Haubitz, Lupusnephritis, Der Nephrologe, 2012, 7, 1, 63

    CrossRef

  8. 8
    I. G. Okpechi, O. E. Ayodele, E. S. W. Jones, M. Duffield, C. R. Swanepoel, Outcome of patients with membranous lupus nephritis in Cape Town South Africa, Nephrology Dialysis Transplantation, 2012,

    CrossRef

  9. 9
    Antonis Fanouriakis, Eleni Krasoudaki, Michail Tzanakakis, Dimitrios T. Boumpas, Recent progress in the treatment of lupus nephritis, Modern Rheumatology, 2012,

    CrossRef

  10. 10
    Louise Watson, Michael W. Beresford, Urine biomarkers in juvenile-onset SLE nephritis, Pediatric Nephrology, 2012,

    CrossRef

  11. 11
    Guillermo J. Pons-Estel, Rosa Serrano, Miguel A. Plasín, Gerard Espinosa, Ricard Cervera, Epidemiology and management of refractory lupus nephritis, Autoimmunity Reviews, 2011, 10, 11, 655

    CrossRef

  12. 12
    Crispin Abarientos, Kirk Sperber, Deborah L Shapiro, Wilbert S Aronow, Chun Peng Chao, Julia Y Ash, Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy, Expert Opinion on Drug Safety, 2011, 10, 5, 705

    CrossRef

  13. 13
    Graciela S. Alarcón, Multiethnic lupus cohorts: What have they taught us?, Reumatología Clínica, 2011, 7, 1, 3

    CrossRef

  14. 14
    Senq-J Lee, Earl Silverman, Joanne M. Bargman, The role of antimalarial agents in the treatment of SLE and lupus nephritis, Nature Reviews Nephrology, 2011, 7, 12, 718

    CrossRef

  15. 15
    Earl Silverman, Allison Eddy, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  16. 16
    Brad H. Rovin, Isaac E. Stillman, Systemic Lupus Erythematosus, 2011,

    CrossRef

  17. 17
    Nathalie Costedoat-Chalumeau, Gaëlle Leroux, Jean-Charles Piette, Zahir Amoura, Systemic Lupus Erythematosus, 2011,

    CrossRef

  18. 18
    Jose-Luis Ayensa, Munther Khamashta, Guillermo Ruiz-Irastorza, A new role for antimalarials in systemic lupus erythematosus treatment, International Journal of Clinical Rheumatology, 2010, 5, 3, 299

    CrossRef

  19. 19
    Samuel K. Shinjo, Eloísa Bonfá, Daniel Wojdyla, Eduardo F. Borba, Luis A. Ramirez, Hugo R. Scherbarth, João C. Tavares Brenol, Rosa Chacón-Diaz, Oscar J. Neira, Guillermo A. Berbotto, Ignacio Garcia de la Torre, Eduardo M. Acevedo-Vázquez, Loreto Massardo, Leonor A. Barile-Fabris, Francisco Caeiro, Luis H. Silveira, Emilia I. Sato, Sandra Buliubasich, Graciela S. Alarcón, Bernardo A. Pons-Estel, Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort, Arthritis & Rheumatism, 2010, 62, 3
  20. 20
    Liz Lightstone, Lupus nephritis: where are we now?, Current Opinion in Rheumatology, 2010, 22, 3, 252

    CrossRef

  21. 21
    Stephen D Marks, Kjell Tullus, Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis, Acta Paediatrica, 2010, 99, 7
  22. 22
    Thomas Dörner, Therapy: Hydroxychloroquine in SLE: old drug, new perspectives, Nature Reviews Rheumatology, 2010, 6, 1, 10

    CrossRef

  23. 23
    Evelyne Vinet, Sasha Bernatsky, Samy Suissa, Have some beneficial effects of hydroxychloroquine been overestimated? Potential biases in observational studies of drug effects: Comment on the article by Pons-Estel et al, Arthritis Care & Research, 2009, 61, 11
  24. 24
    Steven C. Vlad, Protective effect of hydroxychloroquine on renal damage may be biased: Comment on the article by Pons-Estel et al, Arthritis Care & Research, 2009, 61, 11
  25. 25
    Paula I. Burgos, Elizabeth L. Perkins, Guillermo J. Pons-Estel, Scott A. Kendrick, Jigna M. Liu, William T. Kendrick, William J. Cook, Bruce A. Julian, Graciela S. Alarcón, Clifton E. Kew, Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institution, Arthritis & Rheumatism, 2009, 60, 9
  26. 26
    Graciela S Alarcón, Risk factors for thrombotic events in patients with systemic lupus erythematosus from different ethnic groups, International Journal of Clinical Rheumatology, 2009, 4, 3, 267

    CrossRef

  27. 27
    Paula I Burgos, Graciela S Alarcón, Thrombosis in systemic lupus erythematosus: risk and protection, Expert Review of Cardiovascular Therapy, 2009, 7, 12, 1541

    CrossRef